Economic Considerations On the Use of Mifamurtide In the Treatment of Osteosarcoma In Spain
Value Health
.
2014 Nov;17(7):A526-7.
doi: 10.1016/j.jval.2014.08.1662.
Epub 2014 Oct 26.
Authors
M Brosa
1
,
Del Muro X García
2
,
J Mora
3
,
A Villacampa
1
,
T Pozo
4
,
C Adán
4
,
M Grande
4
,
E García
4
,
L Cubells
4
Affiliations
1
Oblikue Consulting, Barcelona, Spain.
2
Institut Català d'Oncologia, L'Hosp. de Llobregat, Spain.
3
Hospital Sant Joan de Déu, Esplugues de Llobregat, Spain.
4
Medical Department. Takeda Farmacéutica España, Madrid, Spain.
PMID:
27201662
DOI:
10.1016/j.jval.2014.08.1662
No abstract available